Phase 2 Dose Finding sPIF in Patients With High Panel Reactive Antibodies
Phase 2
Withdrawn
- Conditions
- Panel Reactive Antibodies
- Interventions
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2019-01-03
- Lead Sponsor
- Christopher O'Brien, MD
- Registration Number
- NCT03593421
Phase II AutoImmune Hepatitis
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2019-01-03
- Lead Sponsor
- Christopher O'Brien, MD
- Registration Number
- NCT03593460
sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS
- First Posted Date
- 2014-09-12
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- Christopher O'Brien, MD
- Target Recruit Count
- 36
- Registration Number
- NCT02239562
- Locations
- 🇺🇸
Chief Scientist, BIOINCEPT, LLC / Chairman, (SIEP) / Director, Ob&Gyn CAMcare Health Center, Cherry Hill, New Jersey, United States
🇺🇸Center for Liver Diseases; University of Miami, Miami, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath